REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,214 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,047 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 69.9M shares of 105M outstanding shares and own 66.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.16M shares), Capital World Investors (5.32M shares), STATE STREET CORP (4.8M shares), JPMORGAN CHASE & CO (4.59M shares), WELLINGTON MANAGEMENT GROUP LLP (3.13M shares), LOOMIS SAYLES & CO L P (2.63M shares), GEODE CAPITAL MANAGEMENT, LLC (1.98M shares), PUTNAM INVESTMENTS LLC (1.34M shares), HARRIS ASSOCIATES L P (1.32M shares), and NORTHERN TRUST CORP (1.2M shares).
This table shows the top 1047 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.